Where this thyroid cancer information comes from
On this page are the major sources of information that we use to put together this section of CancerHelp UK.
All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had thyroid cancer, live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.
Cancer Research UK
CancerStats Series
The Royal College of Radiologists
Information for patients and carers
US National Cancer Institute
Information on the treatment of thyroid cancer
Principles and practice of oncology (8th edition)
De Vita, V.T., Hellman, S. and Rosenberg S.A.
Lippincott, Wiliams and Wilkins, 2008
Cancer and its management (6th edition)
J Tobias and D Hochhauser
Wiley-Blackwell, 2010
Referral Guidelines for Suspected Cancer
The National Institute for Health and Clinical Excellence (NICE), June 2005
Link to the referral guidelines on the NICE website
Guidelines for the management of thyroid cancer in adults
The Royal College of Physicians and British Thyroid Association, September 2007
Link to the British Thyroid Association website
Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. F Pacini, MG Castaggna, L Brilli, L Jost on behalf of the ESMO Guidelines Working Group, Annals of Oncology, 2008: May;19 Supplement 2.
New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era. J Capdevila, G Argiles, V Rodriguez-Frexinos, I Nuñez, J Tabernero. Discovery Medicine, 2010. Feb;9(45):153-62.
Complications of radioactive iodine treatment of thyroid carcinoma. Lee SL.,The Journal of the National Comprehensive Cancer Network 2010 Nov 8(11);1277–86
Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma. V Rufini, P Castaldi, G Treglia, G Perotti, MD Gross, A Al-Nahhas, D Rubello. Biomedicine and Pharmacotherapy, 2008. Mar;62(3):139-46. Epub 2007 Aug 20.
Chemoembolization for liver metastases from medullary thyroid carcinoma. J Fromigué, T De Baere, E Baudin, C Dromain, S Leboulleux, M Schlumberger. Journal of Clinical Endocrinology and Metabolism, 2006. Jul;91(7):2496-9. Epub 2006 Apr 11.
Advances in the management of hereditary medullary thyroid cancer. Machens, A., Ukkat, J., Brauckhoff, M., Gimm, O. & Dralle, H.. Journal of Internal Medicine, (2005); 257: 50-59.
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. F Pacini, M Schlumberger, H Dralle, R Elisei, J Smit, W Wiersinga and the European Thyroid Cancer Taskforce. European Journal of Endocrinology (2006); 154: 787-803.
Is adjuvant therapy useful in patients with papillary carcinoma smaller than 2 cm? PW Rosário, MA Borges, MM Valadão, FP Vasconcelos, LL Rezende, EL Padrão, AL Barroso, S Purisch. Thyroid, 2007 Dec;17(12): 1225-8.
Dr Caroline Brammer, Consultant Clinical Oncologist
Dr Prakash Ramachandra, MBBS, MRCP, FRCR
Mr Simon Smith, Consultant General Surgeon
Dee McLean – McDee Art, Medical Illustration







Read article




